Endonovo Reports Positive Results in Critical Limb Ischemia Study Using Non-Invasive Medical Device

Endonovo Therapeutics (OTCQB: ENDV) a commercial-stage developer of non-invasive wearable Electroceutical™ devices, today announced positive results from a study of critical limb ischemia (CLI) in mice.

As quoted in the press release:

Animals treated three times per day with the Company’s Pulsed Electromagnetic Fields (PEMF) device had significantly higher blood flow (ratio of blood flow of the ischemic limb to blood flow of non-ischemic limb) at day 7 and 14 (57% and 71%, versus 36% and 52%) versus the controls. Furthermore, animals treated with PEMF three times per day had significantly improved foot movement scores and less tissue damage in the ischemic hind limb versus the controls.

Click here to read the full press release.